T/HENANPA 012-2024 Active Group standards

T/HENANPA 012-2024 National Drug Adverse Reaction Monitoring System Specification for Reporting Individual Case Information

T/HENANPA 012-2024 National Drug Adverse Reaction Monitoring System Specification for Reporting Individual Case Information

Publish Date: 2024-04-02 Implement Date: 2024-04-07 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Download

Basic Information

Standard Code: T/HENANPA 012-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2024-04-02
Implement Date: 2024-04-07
Pages: 13 pages

Scope

Main technical content: This standard specifies the relevant terms and definitions of information in the national adverse drug reaction monitoring system, as well as the standard collection of information on individual adverse drug reactions/incident reports, the correct processing of information, the accurate filling out of information, and the standard reporting of information. It is applicable to the collection, processing, and standardized management of individual adverse drug reactions/incident reports in medical institutions at all levels. It provides guidance for medical institutions at all levels to improve the level of ADR/ADE monitoring and the quality of individual ADR/ADE reports, thereby effectively identifying and controlling drug risks

Development Information

Pages: 13 pages

Related Standards

Contact Us